Literature DB >> 35510123

Serous fluids and hematolymphoid disorders.

Ali Gabali1.   

Abstract

Diagnosing hematolymphoid neoplasm by evaluating fine-needle aspiration (FNA) cytology sample is controversial and requires experience and clinical skills. This concept becomes more challenging when evaluating hematolymphoid neoplasm in body fluid. Differentiating between low-grade lymphoma and reactive lymphocytes is often difficult by morphology alone as reactive lymphoid cells may acquire activation morphology from being exposed to different cytokines within the body fluid. However, in most cases there are specific features that may aid in differentiating small reactive from non-reactive lymphocytes including the round shape of the nucleus, the absence of visible nucleoli and the presence of fine clumped chromatin. In large cell lymphoma and leukemia cells involvement of body fluid this concept becomes less challenging. Large cell lymphoma and leukemia cells tend to have large size nuclei, less mature chromatin, and visible nucleoli with and without cytoplasmic vacuoles. However, to reach accurate diagnosis and subclassification, the utilizing of flow cytometry, to confirm monoclonality, and other ancillary studies such immunocytochemistry, cytogenetics and molecular studies is needed. This review article will be incorporated finally as one of the chapters in CMAS (CytoJournal Monograph/Atlas Series) #2. It is modified slightly from the chapter by the initial authors in the first edition of Diagnostic Cytopathology of Serous Fluids.
© 2022 Cytopathology Foundation Inc, Published by Scientific Scholar.

Entities:  

Keywords:  Body Fluid; Large Cell; Leukemia; Lymphoma; Small Cell

Year:  2022        PMID: 35510123      PMCID: PMC9063582          DOI: 10.25259/CMAS_02_12_2021

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.345


  83 in total

1.  Pulmonary complications in chronic lymphocytic leukemia.

Authors:  Shahid Ahmed; Anita K Siddiqui; Leonard Rossoff; Cristina P Sison; Kanti R Rai
Journal:  Cancer       Date:  2003-11-01       Impact factor: 6.860

2.  Cytologic diagnosis of syphilitic pleuritis: a case report.

Authors:  P Zaharopoulos; J Wong
Journal:  Diagn Cytopathol       Date:  1997-01       Impact factor: 1.582

Review 3.  [Eosinophilia and ascites as an expression of a subserous form of eosinophilic gastroenteritis].

Authors:  M P Sánchez-Fayos; R Miranda; L Renedo; J C Porres; C Hernández Guío
Journal:  Rev Clin Esp       Date:  1992-06       Impact factor: 1.556

4.  Volume and cellular content of normal pleural fluid in humans examined by pleural lavage.

Authors:  M Noppen; M De Waele; R Li; K V Gucht; J D'Haese; E Gerlo; W Vincken
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

5.  Cytologically malignant lymphoid pericardial effusion with benign clinical outcome.

Authors:  Micha Maeder; Peter Spieler; Reto Krapf; Markus Diethelm
Journal:  Swiss Med Wkly       Date:  2005-06-25       Impact factor: 2.193

6.  Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.

Authors:  J R Hallman; K R Geisinger
Journal:  Acta Cytol       Date:  1994 Mar-Apr       Impact factor: 2.319

7.  Diagnosis of granulocytic sarcoma on pleural effusion cytology: report of a case.

Authors:  Andrew J Dettrick; Thomas Robertson; Kirk L Morris
Journal:  Diagn Cytopathol       Date:  2004-08       Impact factor: 1.582

8.  The etiology of pleural effusions in an area with high incidence of tuberculosis.

Authors:  L Valdés; D Alvarez; J M Valle; A Pose; E San José
Journal:  Chest       Date:  1996-01       Impact factor: 9.410

Review 9.  Body cavity lymphoma.

Authors:  Valeria Ascoli; Francesco Lo-Coco
Journal:  Curr Opin Pulm Med       Date:  2002-07       Impact factor: 3.155

10.  Eosinophilic pleural effusion: a review of 36 cases.

Authors:  A J Wysenbeek; M Lahav; J A Aelion; L Kaufmann
Journal:  Respiration       Date:  1985       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.